38,244.04 DMD Permanently Burned in the Past 7 Days
On June 25, 2026, the latest on-chain data from DMDAO revealed that a total of 38,244.04 DMD has been permanently burned through the established transaction and wealth management burn mechanisms over the past 7 calendar days.
Approaching the Target Total Supply: As the burning continues, DMD is steadily converging toward its hard cap of 1,000,000 tokens. Driven by ongoing on-chain interactions and native system mechanisms, the overall circulating supply in the market is continuously shrinking.
Robust Business Performance: The steady accumulation of burned tokens directly reflects the underlying market-making system's recent high-frequency spread-capture capabilities and genuine on-chain activity. Powered by this deflationary model, the reduction in circulating supply effectively enhances the value-bearing capacity of existing tokens.
Optimistic Market Liquidity Outlook: With public market trading pairs running smoothly, DMD is progressively integrating into the broader secondary market. This not only attracts a diverse range of external participants to the project but also fosters long-term stability for the liquidity pool and expands the growth potential of the entire ecosystem.
The deflationary mechanism remains in active operation as the market structure continues to optimize. DMDAO will maintain full transparency by continuing to disclose data regularly.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
S&P Dow Jones Partners With Kalshi as Prediction Markets Enter Mainstream
130% Near Protocol (NEAR) Surge in Spot Inflows Secures $1.3 Million

Unable to recover 817 bitcoin, Datavault AI (DVLT.US) stock price slashed in half
Datavault AI has confirmed that it has been unable to withdraw Bitcoin from Biconomy since June, resulting in a failed asset transfer and forcing the company to restate its financial reports. As a result, its share price plummeted by 49.55% in a single day, and its book assets are expected to shrink significantly.

Regenerative medicine device company RegenLab USA (RGNA.US) sets IPO price at $6–$8 per share, aiming to raise $18 million
RegenLab USA announced its IPO terms on Tuesday.
